BACKGROUND: L-arginine (L-Arg) is a semi-essential amino acid that is the substrate for both nitric oxide and polyamine synthesis. Cellular uptake of L-Arg is an active transport process that is subject to competitive inhibition by L-ornithine (L-Orn) and L-lysine (L-Lys). We investigated L-Arg utilization in patients with ulcerative colitis (UC). METHODS: Serum was collected from 14 normal controls and 22 UC patients with pancolitis of moderate or severe activity by histopathology score. The Mayo Disease Activity Index (DAI) and endoscopy subscore were assessed. Serum amino acid levels were measured by high-performance liquid chromatography. Arginine availability index (AAI) was defined as [L-Arg]/([L-Orn] + [L-Lys]). RESULTS: Serum L-Arg levels were significantly associated with histopathologic grade (P = 0.001). L-Arg levels were increased in subjects with severe colitis when compared to those with moderate colitis or normal mucosa. L-Orn + L-Lys levels were also increased in severe colitis, so that AAI was not significantly increased. L-Arg levels were also strongly associated with the endoscopy subscore (P < 0.001). There was a strong correlation between DAI and L-Arg levels (r = 0.656, P < 0.001). CONCLUSIONS: Serum L-Arg levels correlate with UC disease severity but availability is not increased due to competitive inhibition by L-Orn and L-Lys. Our findings suggest that L-Arg uptake by cells in the inflamed colon is defective, which may contribute to the pathogenesis of UC. Studies delineating the mechanism of uptake inhibition could enhance our understanding of UC or lead to novel treatment options.
BACKGROUND:L-arginine (L-Arg) is a semi-essential amino acid that is the substrate for both nitric oxide and polyamine synthesis. Cellular uptake of L-Arg is an active transport process that is subject to competitive inhibition by L-ornithine (L-Orn) and L-lysine (L-Lys). We investigated L-Arg utilization in patients with ulcerative colitis (UC). METHODS: Serum was collected from 14 normal controls and 22 UC patients with pancolitis of moderate or severe activity by histopathology score. The Mayo Disease Activity Index (DAI) and endoscopy subscore were assessed. Serum amino acid levels were measured by high-performance liquid chromatography. Arginine availability index (AAI) was defined as [L-Arg]/([L-Orn] + [L-Lys]). RESULTS: Serum L-Arg levels were significantly associated with histopathologic grade (P = 0.001). L-Arg levels were increased in subjects with severe colitis when compared to those with moderate colitis or normal mucosa. L-Orn + L-Lys levels were also increased in severe colitis, so that AAI was not significantly increased. L-Arg levels were also strongly associated with the endoscopy subscore (P < 0.001). There was a strong correlation between DAI and L-Arg levels (r = 0.656, P < 0.001). CONCLUSIONS: Serum L-Arg levels correlate with UC disease severity but availability is not increased due to competitive inhibition by L-Orn and L-Lys. Our findings suggest that L-Arg uptake by cells in the inflamed colon is defective, which may contribute to the pathogenesis of UC. Studies delineating the mechanism of uptake inhibition could enhance our understanding of UC or lead to novel treatment options.
Authors: Lorena Martín; Mónica Comalada; Luc Marti; Ellen I Closs; Carol L MacLeod; Rafael Martín del Río; Antonio Zorzano; Manuel Modolell; Antonio Celada; Manuel Palacín; Joan Bertran Journal: Am J Physiol Cell Physiol Date: 2005-12-21 Impact factor: 4.249
Authors: Paul Rutgeerts; William J Sandborn; Brian G Feagan; Walter Reinisch; Allan Olson; Jewel Johanns; Suzanne Travers; Daniel Rachmilewitz; Stephen B Hanauer; Gary R Lichtenstein; Willem J S de Villiers; Daniel Present; Bruce E Sands; Jean Frédéric Colombel Journal: N Engl J Med Date: 2005-12-08 Impact factor: 91.245
Authors: G Ricci; G Stabellini; G Bersani; G Marangoni; P Fabbri; G Gentili; V Alvisi Journal: Eur J Gastroenterol Hepatol Date: 1999-08 Impact factor: 2.566
Authors: C Fotiadis; S Adamis; E P Misiakos; M Genetzakis; P T Antonakis; D K Tsekouras; V G Gorgoulis; G C Zografos; A Papalois; M Fotinou; D Perrea Journal: Acta Chir Belg Date: 2007 Mar-Apr Impact factor: 1.090
Authors: Kshipra Singh; Lori A Coburn; Daniel P Barry; Jean-Luc Boucher; Rupesh Chaturvedi; Keith T Wilson Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-02-23 Impact factor: 4.052
Authors: Lori A Coburn; Sara N Horst; Margaret M Allaman; Caroline T Brown; Christopher S Williams; Mallary E Hodges; Jennifer P Druce; Dawn B Beaulieu; David A Schwartz; Keith T Wilson Journal: Inflamm Bowel Dis Date: 2016-08 Impact factor: 5.325
Authors: George P Christophi; Rong Rong; Philip G Holtzapple; Paul T Massa; Steve K Landas Journal: Inflamm Bowel Dis Date: 2012-03-29 Impact factor: 5.325
Authors: Kshipra Singh; Lori A Coburn; Daniel P Barry; Mohammad Asim; Brooks P Scull; Margaret M Allaman; Nuruddeen D Lewis; M Kay Washington; Michael J Rosen; Christopher S Williams; Rupesh Chaturvedi; Keith T Wilson Journal: Am J Physiol Gastrointest Liver Physiol Date: 2013-05-23 Impact factor: 4.052
Authors: Elizabeth A Scoville; Margaret M Allaman; Caroline T Brown; Amy K Motley; Sara N Horst; Christopher S Williams; Tatsuki Koyama; Zhiguo Zhao; Dawn W Adams; Dawn B Beaulieu; David A Schwartz; Keith T Wilson; Lori A Coburn Journal: Metabolomics Date: 2017-12-29 Impact factor: 4.290
Authors: Lori A Coburn; Xue Gong; Kshipra Singh; Mohammad Asim; Brooks P Scull; Margaret M Allaman; Christopher S Williams; Michael J Rosen; M Kay Washington; Daniel P Barry; M Blanca Piazuelo; Robert A Casero; Rupesh Chaturvedi; Zhongming Zhao; Keith T Wilson Journal: PLoS One Date: 2012-03-12 Impact factor: 3.240
Authors: Rudolf Schicho; Rustem Shaykhutdinov; Jennifer Ngo; Alsu Nazyrova; Christopher Schneider; Remo Panaccione; Gilaad G Kaplan; Hans J Vogel; Martin Storr Journal: J Proteome Res Date: 2012-05-17 Impact factor: 4.466